RxDoctor Payments Data

Cortney Black, NP

Family · Anniston, ALNPI 1225481369

Payments from drug & device makers

$1,854in general payments, 2019–2025

Across 108 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$326
  • GSK$231
  • AbbVie$222
  • AstraZeneca$184
  • Pfizer$132
  • Corium, LLC$118
  • plus $640 from 18 others

What the payments were for

  • Food & beverage$1,854100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,854 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$40,197
Medicare patients
161
Services billed
2,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$30,452
EliquisApixaban29$17,994
JardianceEmpagliflozin17$17,878
MounjaroTirzepatide11$16,125
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,254
LinzessLinaclotide13$7,957
Albuterol Sulfate HfaAlbuterol Sulfate57$1,023
Atorvastatin Calcium49$487
Omeprazole24$417
Ondansetron OdtOndansetron34$350
Levothyroxine Sodium44$309
Meloxicam49$309
Tizanidine Hcl31$295
Methocarbamol29$294
Buspirone Hcl16$292

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$326$30,45224 claims
PfizerEliquis$132$17,99429 claims
Boehringer IngelheimJardiance$14$17,87817 claims
Lilly USA, LLCMounjaro$13$16,12511 claims
GSKTrelegy Ellipta$231$9,25414 claims
AbbVieLinzess$222$7,95713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.

Other family in Anniston

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →